We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services
News

CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services

CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services
News

CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CODA Genomics and Integrated Genomics have announced a collaboration which will apply CODA's proprietary Translation Engineering™ protein expression technology to the Pichia yeast expression system.

"Pichia continues to grow in use and success in many markets. We are pleased to work with Integrated Genomics to help increase yield and activity of difficult to express proteins,” said Dr. Robert J. Molinari, CEO of CODA.

“This relationship exemplifies our continued expansion and success in solving protein expression bottlenecks,” Dr. Molinari continued.

"This combination of our proprietary Pichia sequence and metabolic reconstruction with CODA's unique expression optimization technology provides a tremendous opportunity for scientists optimizing protein expression in Pichia," added Dr. John Elling, President of Integrated Genomics.

CODA's proprietary protein Translation Engineering technologies are designed to address protein expression, solubility and activity challenges in rational design steps at all stages of pharmaceutical development.

This utilization of synthetic biology can change the competitive landscape of many businesses which rely on successful protein production.

Integrated Genomics can provide the genomic sequence of Pichia and other cell lines which are crucial for successful protein production.

The sequence, assembly and detailed annotation provided by Integrated Genomics will allow CODA to provide enhanced genes for protein expression without amino acid changes in proteins of interest.

Advertisement